NYSE ARCA | ETF
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 4.51% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.40% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.39% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 4.38% |
| XENE | Xenon Pharmaceuticals Inc | Healthcare | Biotechnology | 4.37% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 4.29% |
| 326030 | Sk Biopharmaceuticals Co Ltd | Healthcare | Biotechnology | 4.26% |
| DNLI | Denali Therapeutics Inc | Healthcare | Biotechnology | 4.21% |
| SRRK | Scholar Rock Holding Corp | Healthcare | Biotechnology | 4.21% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 4.10% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 4.08% |
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 4.05% |
| SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.04% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.98% |
| AXNX | Axonics Modulation Technologies Inc | Healthcare | Medical Devices | 3.69% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.68% |
| LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 3.66% |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd | Healthcare | Biotechnology | 3.17% |
| HLUN-B | H Lundbeck A/S | Healthcare | Drug Manufacturers - Specialty & Generic | 3.03% |
| NEU | Neuren Pharmaceuticals Ltd | Healthcare | Biotechnology | 2.89% |